Stock Name: ParkwayLife Reit
Company Name: PARKWAYLIFE REIT
Company Name: PARKWAYLIFE REIT
| Research House: DBS Vickers | Price Call: BUY | Target Price: 2.66 |
SINGAPORE (Dec 4): DBS Group Research is maintaining its "buy" call on Parkway Life REIT, with a price target of $2.66.
In a Dec 4 report, analysts Derek Tan and Andy Sim says P-Life REIT offers a good balance of visibility and growth. Asset recycling in Japan and future acquisitions are also potential re-rating catalysts for the stock.
P-Life REIT derives its income from a diversified base of healthcare-related properties with Singapore hospitals contributing 64% of revenues, Japan at 36% and Malaysia at less than 1%.
No comments:
Post a Comment